Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Pharmaceutical Combination Comprising Nucleotide And Nucleoside Reverse Transcriptase Inhibitors (Such As Tenofovir And Lamivudine) In Different Parts Of The Dosage Unit
Abstract: A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior, art combination therapies. The invention also provides a pharmaceutical product containing the formulation.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
27 June 2008
Publication Number
37/2008
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application
Applicants
CIPLA LIMITED
289 BELLASIS ROAD, MUMBAI CENTRAL, MUMBAI 400 008,
Inventors
1. LULLA, AMAR
131 MAKER TOWERS, "L" 13TH FLOOR, CUFFE PARADE COLABA, MUMBAI-400 005,
2. MALHOTRA, GEENA
4 Anderson House Opposite Mazgaon Post Office Mazgaon Mumbai-400 010 Maharashtra India
Specification
PLEASE SEE THE SPECIFICATION ATTACHED.
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 1340-MUMNP-2008- FORM 2.pdf | 2022-04-08 |
| 1 | 1340-MUMNP-2008-FORM 3(26-12-2008).pdf | 2008-12-26 |
| 2 | 1340-MUMNP-2008-CORRESPONDENCE(26-12-2008).pdf | 2008-12-26 |
| 2 | 1340-MUMNP-2008- PCT DOCUMENTS.pdf | 2022-04-08 |
| 3 | 1340-MUMNP-2008-FORM 18(24-11-2009).pdf | 2009-11-24 |
| 3 | 1340-MUMNP-2008- PUBLICATION REPORT.pdf | 2022-04-08 |
| 4 | 1340-MUMNP-2008-CORRESPONDENCE(24-11-2009).pdf | 2009-11-24 |
| 4 | 1340-MUMNP-2008-CORRESPONDENCE (9-9-2009).pdf | 2018-08-09 |
| 5 | Form-5.pdf | 2018-08-09 |
| 5 | 1340-MUMNP-2008-CORRESPONDENCE(1-7-2008).pdf | 2018-08-09 |
| 6 | Form-3.pdf | 2018-08-09 |
| 6 | 1340-MUMNP-2008-CORRESPONDENCE(11-8-2008).pdf | 2018-08-09 |
| 7 | Form-1.pdf | 2018-08-09 |
| 7 | 1340-MUMNP-2008-CORRESPONDENCE(IPO)-(4-3-2013).pdf | 2018-08-09 |
| 8 | 1340-MUMNP-2008_EXAMREPORT.pdf | 2018-08-09 |
| 8 | 1340-MUMNP-2008-FORM 1(11-8-2008).pdf | 2018-08-09 |
| 9 | 1340-MUMNP-2008-POWR OF ATTORENY(11-8-2008).pdf | 2018-08-09 |
| 9 | 1340-MUMNP-2008-FORM 1(27-6-2008).pdf | 2018-08-09 |
| 10 | 1340-MUMNP-2008-FORM 13(11-9-2009).pdf | 2018-08-09 |
| 10 | 1340-MUMNP-2008-POWER OF AUTHORITY(11-9-2009).pdf | 2018-08-09 |
| 11 | 1340-MUMNP-2008-FORM 3(27-6-2008).pdf | 2018-08-09 |
| 11 | 1340-MUMNP-2008-FORM 5(27-6-2008).pdf | 2018-08-09 |
| 12 | 1340-MUMNP-2008-FORM 3(27-6-2008).pdf | 2018-08-09 |
| 12 | 1340-MUMNP-2008-FORM 5(27-6-2008).pdf | 2018-08-09 |
| 13 | 1340-MUMNP-2008-FORM 13(11-9-2009).pdf | 2018-08-09 |
| 13 | 1340-MUMNP-2008-POWER OF AUTHORITY(11-9-2009).pdf | 2018-08-09 |
| 14 | 1340-MUMNP-2008-FORM 1(27-6-2008).pdf | 2018-08-09 |
| 14 | 1340-MUMNP-2008-POWR OF ATTORENY(11-8-2008).pdf | 2018-08-09 |
| 15 | 1340-MUMNP-2008-FORM 1(11-8-2008).pdf | 2018-08-09 |
| 15 | 1340-MUMNP-2008_EXAMREPORT.pdf | 2018-08-09 |
| 16 | 1340-MUMNP-2008-CORRESPONDENCE(IPO)-(4-3-2013).pdf | 2018-08-09 |
| 16 | Form-1.pdf | 2018-08-09 |
| 17 | 1340-MUMNP-2008-CORRESPONDENCE(11-8-2008).pdf | 2018-08-09 |
| 17 | Form-3.pdf | 2018-08-09 |
| 18 | 1340-MUMNP-2008-CORRESPONDENCE(1-7-2008).pdf | 2018-08-09 |
| 18 | Form-5.pdf | 2018-08-09 |
| 19 | 1340-MUMNP-2008-CORRESPONDENCE(24-11-2009).pdf | 2009-11-24 |
| 19 | 1340-MUMNP-2008-CORRESPONDENCE (9-9-2009).pdf | 2018-08-09 |
| 20 | 1340-MUMNP-2008-FORM 18(24-11-2009).pdf | 2009-11-24 |
| 20 | 1340-MUMNP-2008- PUBLICATION REPORT.pdf | 2022-04-08 |
| 21 | 1340-MUMNP-2008-CORRESPONDENCE(26-12-2008).pdf | 2008-12-26 |
| 21 | 1340-MUMNP-2008- PCT DOCUMENTS.pdf | 2022-04-08 |
| 22 | 1340-MUMNP-2008-FORM 3(26-12-2008).pdf | 2008-12-26 |
| 22 | 1340-MUMNP-2008- FORM 2.pdf | 2022-04-08 |